To start your customized experience click the start button
Customize ?  
Cancer Types
Quick Links
Award Programs
About Us
Contact Us
Privacy Policy
Terms & Conditions
Face Book
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Lung Cancer

Jarushka Naidoo, MBBCh
Immunotherapy use continues to expand in the cancer treatment space. So, it is important that patients and caregivers understand its potential side effects.
Brielle Urciuoli
New targeted therapies and immunotherapy treatments have rapidly improved the outcomes of patients with cancer. But not everyone is so lucky to have access to these agents.
The Food and Drug Administration (FDA) has approved a supplemental biologics license application adding a four-week dosing schedule for Opdivo (nivolumab) across several of the PD-1 inhibitor’s indications.
Katie Kosko
Music has a way of deeply touching people’s emotions. Songs can stir memories that create joy, loss, happiness and heartbreak. Emotions like these are only part of the mix of feelings that accompany a lung cancer diagnosis. For Hildy Grossman, music has the ability to touch a person’s highest emotional and spiritual level. Because of this, music can be healing, comforting, therapeutic, a means of hope.
Katie Kosko
Researchers studied state-specific measures of disease incidence, adult smoking prevalence, radon zones, five-year survival, stage at diagnosis, five-year survival by stage at diagnosis, surgery as part of the first course of treatment and accredited lung cancer screening centers.
Brielle Urciuoli
Treatment of HIV has drastically improved since the 1980s, but many of these individuals are still facing barriers to proper cancer care.
Kristie L. Kahl
To help educate patients and enable health care teams to effectively manage these side effects, the National Comprehensive Cancer Network (NCCN) and the American Society of Clinical Oncology (ASCO) issued new guidelines on understanding and managing immunotherapy-related toxicities.
Jason M. Broderick
FDA approves first treatment approved for stage 3 unresectable non-small cell lung cancer to reduce the risk of the cancer progressing, when the cancer has not worsened after chemoradiation.
Katie Kosko
Roswell Park Cancer Center researchers shed light on disease incidence among women.
Jason Harris
Lorlatinib was granted a priority review to a new drug application (NDA) for patients with ALK-positive metastatic non–small cell lung cancer (NSCLC) who have progressed on one or more ALK tyrosine kinases inhibitors (TKIs).

Sign In

Not a member? Sign up now!
Continue without login

Sign Up

In Treatment

Maintenance/Hormone Treatment

Out of Treatment


Healthcare Professional

Not Applicable